Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1995 1
1996 1
1999 1
2000 3
2001 1
2002 1
2003 1
2004 1
2005 2
2006 3
2007 4
2009 2
2010 1
2011 3
2014 2
2015 1
2016 5
2017 3
2018 4
2019 3
2020 1
2021 2
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor.
Xu H, Jesson MI, Seneviratne UI, Lin TH, Sharif MN, Xue L, Nguyen C, Everley RA, Trujillo JI, Johnson DS, Point GR, Thorarensen A, Kilty I, Telliez JB. Xu H, et al. Among authors: telliez jb. ACS Chem Biol. 2019 Jun 21;14(6):1235-1242. doi: 10.1021/acschembio.9b00188. Epub 2019 May 22. ACS Chem Biol. 2019. PMID: 31082193
Editorial: JAK inhibition in autoimmune and inflammatory diseases.
Telliez JB, Gadina M, Ghoreschi K, Silvennoinen O, Spinelli FR. Telliez JB, et al. Front Immunol. 2022 Dec 28;13:1120281. doi: 10.3389/fimmu.2022.1120281. eCollection 2022. Front Immunol. 2022. PMID: 36643918 Free PMC article. No abstract available.
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis.
Veale DJ, McGonagle D, McInnes IB, Krueger JG, Ritchlin CT, Elewaut D, Kanik KS, Hendrikx T, Berstein G, Hodge J, Telliez JB. Veale DJ, et al. Among authors: telliez jb. Rheumatology (Oxford). 2019 Feb 1;58(2):197-205. doi: 10.1093/rheumatology/key070. Rheumatology (Oxford). 2019. PMID: 29618084 Free PMC article. Review.
Network pharmacology of JAK inhibitors.
Moodley D, Yoshida H, Mostafavi S, Asinovski N, Ortiz-Lopez A, Symanowicz P, Telliez JB, Hegen M, Clark JD, Mathis D, Benoist C. Moodley D, et al. Among authors: telliez jb. Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9852-7. doi: 10.1073/pnas.1610253113. Epub 2016 Aug 11. Proc Natl Acad Sci U S A. 2016. PMID: 27516546 Free PMC article.
Jak3 deficiency blocks innate lymphoid cell development.
Robinette ML, Cella M, Telliez JB, Ulland TK, Barrow AD, Capuder K, Gilfillan S, Lin LL, Notarangelo LD, Colonna M. Robinette ML, et al. Among authors: telliez jb. Mucosal Immunol. 2018 Jan;11(1):50-60. doi: 10.1038/mi.2017.38. Epub 2017 May 17. Mucosal Immunol. 2018. PMID: 28513593 Free PMC article.
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors.
Casimiro-Garcia A, Trujillo JI, Vajdos F, Juba B, Banker ME, Aulabaugh A, Balbo P, Bauman J, Chrencik J, Coe JW, Czerwinski R, Dowty M, Knafels JD, Kwon S, Leung L, Liang S, Robinson RP, Telliez JB, Unwalla R, Yang X, Thorarensen A. Casimiro-Garcia A, et al. Among authors: telliez jb. J Med Chem. 2018 Dec 13;61(23):10665-10699. doi: 10.1021/acs.jmedchem.8b01308. Epub 2018 Nov 30. J Med Chem. 2018. PMID: 30423248
46 results